Griet Wim Bert Schepens

Title: Griet Wim Bert Schepens: Innovator in Influenza Treatment

Introduction

Griet Wim Bert Schepens is a notable inventor based in Sint-Katelijne-Waver, Belgium. He has made significant contributions to the field of medical science, particularly in the development of treatments for influenza. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving public health.

Latest Patents

Griet Wim Bert Schepens holds a patent for "Piperazine derivatives for influenza virus inhibitions." This invention provides piperazine derivatives that exhibit high affinity to the stem region of influenza hemagglutinin. The derivatives demonstrate high virus neutralization activity while maintaining low cytotoxicity. Additionally, the patent includes pharmaceutical compositions comprising these piperazine derivatives, methods for their preparation, and their use in medical prevention or treatment, especially for influenza.

Career Highlights

Griet Wim Bert Schepens is associated with Janssen Vaccines & Prevention B.V., where he continues to contribute to innovative research and development in the pharmaceutical industry. His work is pivotal in advancing treatments that can help combat influenza and improve patient outcomes.

Collaborations

Griet has collaborated with several professionals in his field, including Maria Van Dongen and Jaroslaw Juraszek. These collaborations have enhanced the research and development processes, leading to more effective solutions in the fight against influenza.

Conclusion

Griet Wim Bert Schepens is a distinguished inventor whose work in developing piperazine derivatives for influenza treatment exemplifies his commitment to medical innovation. His contributions are vital in the ongoing battle against viral infections, particularly influenza.